Third-Variable Effects: Tools to Understand Who, When, Why, and How Patients Benefit From Surgical Prehabilitation.


Journal

The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340

Informations de publication

Date de publication:
02 2021
Historique:
received: 23 06 2020
revised: 19 08 2020
accepted: 16 09 2020
pubmed: 2 11 2020
medline: 26 1 2021
entrez: 1 11 2020
Statut: ppublish

Résumé

Prehabilitation is a new field of research that aims to optimize modifiable surgical risk factors before surgery to improve patient-oriented outcomes preoperatively and postoperatively. As with any new intervention, the pressing questions that arise include what interventions work, for whom they work, and when do they work best? Given that prehabilitation can be resource intensive, and that preoperative patient characteristics are likely to produce variation in response to treatment, establishing answers to these questions is critical for successful implementation of prehabilitation in clinical practice. The objective of this review article is to describe the illuminating potential of including "third-variable effects" into the integration of research design; by planning for and including measurements of mediators, moderators, and confounders in the design and analysis of prehabilitation research, we can begin to answer practical, clinically relevant questions.

Identifiants

pubmed: 33129504
pii: S0022-4804(20)30692-2
doi: 10.1016/j.jss.2020.09.026
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

443-452

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Chelsia Gillis (C)

Cumming School of Medicine, Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. Electronic address: Chelsia.gillis@ucalgary.ca.

Leah Gramlich (L)

Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

S Nicole Culos-Reed (SN)

Faculty of Kinesiology and Department of Oncology, Cumming School of Medicine, University of Calgary. Psychosocial Resources, Tom Baker Cancer Centre, Cancer Care, Alberta Health Services, Calgary, Alberta, Canada.

Tolulope T Sajobi (TT)

Cumming School of Medicine, Department of Community Health Sciences & O'Brien Institute for Public Health, University of Calgary, Calgary, Canada.

Kirsten M Fiest (KM)

Department of Critical Care Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Francesco Carli (F)

Department of Anesthesia, McGill University Health Center, Montreal, Quebec, Canada.

Tanis R Fenton (TR)

Department of Community Health Sciences, Institute of Public Health, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada; Nutrition Services, Alberta Health Services, Calgary, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH